Cure of cervical cancer using 252Cf neutron brachytherapy.

Chromosome abnormalities in human epithelial ovarian malignancies.

Characterization of high specific activity 16 alpha-123I Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.

Characterization of high specific activity 16 alpha-123I Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.

[Anonymous].  1990.  Characterization of high specific activity 16 alpha-123I Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.. Cancer research. 50(24):7799-805.

Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.

[Anonymous].  1991.  The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.. Gynecologic oncology. 42(3):245-9.

A review of californium-252 neutron brachytherapy for cervical cancer.

Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma.

Specimen findings and survival after preoperative 252Cf neutron brachytherapy for stage II cervical carcinoma.

Predictive value of specimen histology after preoperative radiotherapy in the treatment of bulky/barrel carcinoma of the cervix.

Phase II trial of didemnin-B in advanced epithelial ovarian cancer. A Southwest Oncology Group study.